Which multimodal neuromonitoring modalities and target parameters are recommended for ICU patients at risk of secondary brain injury (e.g., traumatic brain injury, subarachnoid hemorrhage, intracerebral hemorrhage, severe stroke, post‑cardiac arrest, or receiving high‑dose sedatives)?

Multimodal Neuromonitoring in the ICU

For ICU patients at risk of secondary brain injury, implement a core monitoring platform consisting of intracranial pressure (ICP) with cerebral perfusion pressure (CPP), continuous electroencephalography (cEEG), and brain tissue oxygenation (PbtO2), supplemented by cerebral microdialysis and transcranial Doppler when resources permit. 1

Core Monitoring Modalities and Target Parameters

1. Intracranial Pressure (ICP) and Cerebral Perfusion Pressure (CPP)

ICP and CPP monitoring are fundamental and should be implemented as part of protocol-driven care in all patients at risk of elevated intracranial pressure based on clinical and imaging features. 1

Technical approach:

• Use either parenchymal ICP monitors or external ventricular drains (EVD); both provide reliable and accurate data 1
• In patients with hydrocephalus, prefer EVD when safe and practical 1
• Target ICP threshold: <20-25 mmHg (though the exact threshold remains uncertain in the literature) 1
• Monitor CPP continuously; optimal values vary by individual patient and disease state 1
• Interpret instantaneous ICP values within the context of trends, CPP, and clinical evaluation—not as isolated numbers 1

Critical caveat: ICP monitoring must be combined with clinical evaluation and imaging. The BEST-TRIP trial demonstrated that while ICP-guided protocols are valuable, clinical assessment remains fundamental to all management decisions. 1

2. Continuous Electroencephalography (cEEG)

Implement urgent EEG (within 60 minutes) for patients with convulsive status epilepticus not returning to baseline, and use continuous EEG monitoring for all comatose patients with unexplained altered consciousness. 1

Specific indications requiring strong recommendations:

• All patients with acute brain injury and unexplained persistent altered consciousness 1
• Convulsive status epilepticus patients not returning to functional baseline within 60 minutes after medication 1
• All comatose patients after cardiac arrest during therapeutic hypothermia and within 24 hours of rewarming 1
• Comatose subarachnoid hemorrhage patients to detect delayed cerebral ischemia when neurological examination is unreliable 1

Why continuous over routine EEG: Routine 30-minute EEG recordings miss nonconvulsive seizures in approximately 50% of patients with seizures compared to prolonged monitoring. 1 Cyclic seizure patterns are only detectable with continuous recording. 1

Important limitation: Do not use bispectral index (BIS) monitoring for brain-injured ICU patients—data show large intra- and inter-individual variability with significant interferences. 1

3. Brain Tissue Oxygenation (PbtO2) and Jugular Venous Oximetry (SjvO2)

Monitor brain oxygen using PbtO2 or SjvO2 in patients with or at risk of cerebral ischemia and/or hypoxia. 1

PbtO2 monitoring:

• Normal values: 20-35 mmHg (exact values vary slightly by device type and probe location) 1
• Provides accurate data for up to 10 days 1
• Measures responses to interventions (CPP changes, ventilator adjustments, sedation, transfusion) 1
• Probe location should be determined by diagnosis, lesion type/location, and technical feasibility 1
• Critical threshold: Persistently low PbtO2 strongly predicts mortality and unfavorable outcomes 1

SjvO2 monitoring:

• Normal range: 55-75% 1
• Ischemia threshold: <55% 1
• Detects both ischemia and hyperemia (unlike PbtO2) 1
• More technically challenging than PbtO2—positioning errors, clot formation, and poor sampling technique frequently compromise accuracy 1
• Cannot reliably exclude regional ischemia even with normal global values 1

Clinical application: Use brain oxygen monitoring to guide ICP/CPP therapy, identify refractory intracranial hypertension, manage delayed cerebral ischemia, and select patients for second-tier therapy. 1

4. Cerebral Microdialysis

Consider cerebral microdialysis for monitoring brain metabolism in patients at risk of secondary brain injury, particularly when other modalities suggest metabolic crisis. 1

Key metabolic markers:

• Lactate, pyruvate, glucose concentrations in brain extracellular fluid 1
• Lactate/pyruvate ratio (elevated indicates metabolic crisis)
• Probe location depends on diagnosis and lesion location 1

Prognostic value: Abnormal metabolic patterns correlate with outcomes and can guide therapeutic interventions, though this requires specialized expertise in interpretation. 1

5. Transcranial Doppler (TCD)

Use TCD primarily for detecting vasospasm in subarachnoid hemorrhage patients and assessing cerebral blood flow in select cases. 1

Specific application in SAH:

• TCD predicts angiographic vasospasm with good sensitivity and specificity 1
• Less accurate for predicting delayed ischemic neurological deficits 1
• Improve predictive power by incorporating the Lindegaard ratio and rate of velocity increase 1
• Transcranial color-coded duplex sonography (TCCS) improves accuracy 1

Important limitation: No published studies demonstrate improved outcomes from treatment strategies directed solely by CBF monitoring devices. 1

Systemic Monitoring Requirements

Implement systemic pulse oximetry in all patients and end-tidal capnography in all mechanically ventilated patients, supported by arterial blood gas measurements. 1

Oxygenation targets:

• Avoid both hypoxemia (clearly harmful) and hyperoxia (linked to worse outcomes)
• Target normoxia: PaO2 80-120 mmHg 2
• Avoid unnecessary supplemental oxygen 2

Integration Strategy: The Multimodal Approach

The power of neuromonitoring lies not in individual modalities but in their integration. 1, 3, 4

Hierarchical implementation algorithm:

1. Baseline tier (all patients): Clinical examination, systemic monitoring (ECG, pulse oximetry, blood pressure), arterial blood gases
2. Standard tier (comatose/sedated patients at risk): ICP/CPP monitoring + cEEG
3. Enhanced tier (refractory cases or specific indications): Add PbtO2 or SjvO2 based on pathology
4. Advanced tier (specialized centers with expertise): Add cerebral microdialysis and/or TCD

Critical principle: ICP monitoring is a mandatory prerequisite when using other intracranial monitors—it provides the framework for optimal interpretation of all other modalities. 1

Disease-Specific Considerations

Tailor monitoring indications and methods to specific diagnoses:

• Traumatic brain injury: ICP/CPP + PbtO2 + cEEG as core platform 1
• Subarachnoid hemorrhage: ICP/CPP + cEEG + TCD for vasospasm detection 1
• Intracerebral hemorrhage: ICP/CPP + cEEG; consider PbtO2 in perilesional tissue 1
• Post-cardiac arrest: Mandatory cEEG during and after therapeutic hypothermia 1
• Severe stroke: ICP/CPP if at risk for malignant edema + cEEG 1

Common Pitfalls to Avoid

1. Do not rely on ICP alone for prognostication—while refractory ICP elevation predicts mortality, ICP per se does not provide useful prognostic markers of functional outcome 1

2. Do not use monitoring data in isolation—no monitor changes outcomes by itself; outcomes depend on how information is interpreted and integrated into treatment decisions 1

3. Do not assume normal global measures exclude regional pathology—normal SjvO2 can miss regional ischemia; consider probe location carefully 1

4. Do not delay EEG in status epilepticus—implement within 60 minutes for patients not returning to baseline 1

5. Recognize that clinical examination remains fundamental—monitoring supplements but does not replace clinical assessment, particularly in patients where examination is confounded by sedation, analgesia, or neuromuscular blockade 1